Skip to content
OpenCapital
Get started

Alignment Healthcare ALHC Restricted marketable debt and other securities (Note 6)

Restricted marketable debt and other securities (Note 6) at other companies

Blue Owl Technology Finance Corp. logo
Blue Owl Technology Finance Corp.OTF
$1B-44.4%
Credit Acceptance logo
Credit AcceptanceCACC
$109.4M+0.4%
Fulton Financial logo
Fulton FinancialFULT
$119.95M-11.9%
Atlantic Union Bankshares logo
Atlantic Union BanksharesAUB
$177.51M+77.0%
First Solar logo
First SolarFSLR
$214.67M+2.0%
Citigroup logo
CitigroupC
$6.29B+9.7%

Other financials

Income statement

See full
Revenue$1.2B+33.3%
Operating income$15.5M+387%
Net income$11.4M+225%
EPS (diluted)$0.05+200%

Balance sheet

See full
Cash & equivalents$707.7M+57.9%
Total debt$323.6M+0.5%
Total equity$206.9M+91.3%
Total assets$1.3B+40.9%

Cash flow

See full
Operating cash flow$128.7M+674%
CapEx$7.4M-10.8%
Free cash flow$121.3M+1,350%

Valuation

See full
Market cap$4.52B+0.8%

Profitability

See full
Operating margin0.1%0.0pp
Net margin0.5%+0.2pp
FCF margin4.1%—

Returns & leverage

See full
Return on equity12.6%+6.8pp
Debt / equity1.6×-1.4×
Current ratio1.6×-0.1×

Where this comes from

Reported directly by Alignment Healthcare in its filing.

Tagged under the XBRL concept us-gaap:RestrictedInvestmentsAtFairValue.

The official record: Alignment Healthcare’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Alignment Healthcare's restricted marketable debt and other securities (note 6).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Alignment Healthcare's restricted marketable debt and other securities (note 6)?
Alignment Healthcare (ALHC) reported restricted marketable debt and other securities (note 6) of $2.35M in Q1 2026.
How has Alignment Healthcare's restricted marketable debt and other securities (note 6) changed year-over-year?
Alignment Healthcare's restricted marketable debt and other securities (note 6) increased by 0.8% year-over-year, from $2.33M to $2.35M.
What is the long-term trend for Alignment Healthcare's restricted marketable debt and other securities (note 6)?
Over 2 years (2023 to 2025), Alignment Healthcare's restricted marketable debt and other securities (note 6) has grown at a 15.6% compound annual growth rate (CAGR), from $1.76M to $2.35M.